Both AstraZeneca and MSD have tied lucrative licensing deals for two of LaNova’s oncology assets in recent years.

Nifty rose above 25,100 and Sensex gained 76 points, recovering from earlier losses led by sectoral strength.Stock-Specific ...

With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up ...

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA), in a historic step, has issued a powerful national call to ...

The Sri Lanka Export Development Board (EDB) initiated a constructive dialogue with the National Initiative for R&D ...

Alliance Pharmaceuticals, a U.S. based pharmaceutical solutions provider, announced its new partnership with TrueMed, an AI-based anti-counterfeit detection company. The partnership was formed with ...

Moreover, the aging global population and the expansion of healthcare access are amplifying demand for reliable injectable ...

What happens if the US ties drug prices to other nations? Discover how the most-favored-nation policy could shake the global ...

Varda Space Industries secures $187 million in funding to advance its groundbreaking technology for drug manufacturing in ...

ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, announced today that its 2024 Annual Report has ...

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Wednesday, August 6, 2025, and will hold a ...